Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059243) titled 'Prospective cohort study of Paclitaxel plus Carboplatin plus Bevacizumab Therapy as First Line Chemotherapy for Advanced Ovarian Clear cell Carcinoma' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Chiba University Hospital
Condition:
Condition - Advanced ovarian clear cell carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - We investigate the efficacy and safety of the combination chemotherapy of paclitaxal, carboplarin and bevacizumab in patients with advanced ovarian clear cell carcinoma (stage III/IV).
Basic objectives2 - Safety,Eff...